The United States Food and Drug Administration (FDA) By Global Compliance Seminar (LinkedIn; Twitter) In a recent warning letter, the FDA has warned the drug manufacturer Emcure (Pharmaceuticals Ltd). The following provides key observations made by the FDA inspectors and you are kindly
FDA Warning Letter The United States Food and Drug Administration (FDA) issued a warning letter to the following drug manufacturer, citing numerous violations. The warning letter is downloadable below in PDF. WL: 320-16-02 November 5, 2015 Mr. Satish Reddy Chairman Dr.
FDA Warning Letter to C.R. Bard VIA UNITED PARCEL SERVICE / SIGNATURE REQUIRED July 13, 2015 W/L # 27-15 Chairman and Chief Executive Officer, C.R. Bard Inc. 730 Central Ave.. Murray Hill, NJ 07974 Dear Mr. Ring: During inspection of your C.R. Bard
FDA Warning Letter to Hospira Spa 3/31/15 CERTIFIED MAIL/RETURN RECEIPT REQUESTED WL: 320-15-08 March 31, 2015 Mr. Michael Ball Chief Executive Officer Hospira S.p.A. 275 N. Field Drive Lake Forest, IL 60045 USA Dear Mr. Ball: During our May 5-9 and 12-13,
FDA Warning Letter Issued to Tiller MIND BODY, Inc. 2/25/15 During an inspection of your firm located in San Antonio, Texas on June 23, 2014 through June 26, 2014, an investigator from the United States Food and Drug Administration (FDA) determined
FDA Warning Letter Issued to the Zizion Group LLC 3/12/15 The Food and Drug Administration (FDA) has reviewed your Internet website http://yesprpkit.com. Your website states that your Yes PRP Kit is an ““Easy and accurate PRP-Kit” for medical staffs.” Copies of